Autolus Therapeutics PLC
F:6A3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Autolus Therapeutics PLC
F:6A3A
|
UK |
|
C
|
Cinis Fertilizer AB
F:C05
|
SE |
|
M
|
MyMD Pharmaceuticals Inc
F:DQS
|
US |
|
T
|
TransAlta Renewables Inc
F:0TA
|
CA |
|
S
|
SBI Insurance Group Co Ltd
F:EEW
|
JP |
|
C
|
Consolidated Communications Holdings Inc
F:C8C
|
US |
|
Alconix Corp
F:Y08
|
JP |
|
E
|
Eisai Co Ltd
DUS:EII
|
JP |
|
C
|
China Evergrande Group
DUS:EV1
|
CN |
|
K
|
Kape Technologies PLC
F:8C2
|
UK |
|
F
|
Farm 51 Group SA
F:F51
|
PL |
|
Aoyama Trading Co Ltd
OTC:AYAMF
|
JP |
Shareholder Yield
Current shareholder yield for 
6A3A is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
6A3A Price
Autolus Therapeutics PLC
| Average Annual Return | 23.1% |
| Standard Deviation of Annual Returns | 139.76% |
| Max Drawdown | -86% |
| Market Capitalization | 622.8m EUR |
| Shares Outstanding | 265 928 023 |
| Percentage of Shares Shorted |
N/A
|
